Vyant Bio Inc. buy tamam
Start price
07.12.17
/
50%
€303.08
Target price
07.12.18
€811.80
Performance (%)
-90.00%
End price
07.12.18
€30.30
Summary
This prediction ended on 07.12.18 with a price of €30.30. The BUY prediction by tamam for Vyant Bio Inc. performed very badly with a performance of -90.00%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
| iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
| iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
| iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by tamam for this prediction
In the thread Cancer Genetics Inc. diskutieren
tamam stimmt der Buy-Einschätzung von melinda zu
tamam stimmt am 07.12.2017 der Buy-Einschätzung von melinda aber mit dem Kursziel 6 $ zu.
Überschrift: diagnostics
Cancer Genetics (NASDAQ:CGIX) initiated with Buy rating and $6 (179% upside) price target by Maxim Group.
(Laufzeit überschritten)